List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 78 studies with search of:   Australia, Tasmania
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: exemestane;   Drug: tamoxifen citrate;   Drug: triptorelin;   Procedure: adjuvant therapy
2 Recruiting Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
3 Completed Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
Condition: Heart Failure, Congestive
Intervention: Drug: Levosimendan
4 Active, not recruiting Chemotherapy and Radiotherapy for Osteolymphoma
Condition: Osteolymphoma
Interventions: Drug: Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone.;   Procedure: Radiotherapy
5 Recruiting Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia
Condition: Pneumonia
Intervention: Drug: Tifacogin
6 Recruiting Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: exemestane;   Drug: tamoxifen citrate;   Drug: triptorelin;   Procedure: adjuvant therapy;   Procedure: oophorectomy;   Procedure: radiation therapy
7 Recruiting Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Cyclophosphamide;   Radiation: Radiotherapy;   Drug: Vincristine;   Drug: Prednisolone;   Drug: Rituximab
8 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
9 Recruiting Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Interventions: Drug: cyclophosphamide;   Drug: goserelin
10 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
11 Active, not recruiting The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Glargine;   Drug: Humalog Low Mix
12 Recruiting Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
13 Recruiting E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes and Refractory to the Most Recent Chemotherapy
Condition: Metastatic Breast Cancer
Interventions: Drug: E7389;   Drug: Capecitabine
14 Active, not recruiting Phase 3 Trial of CP-675,206 Versus Either Dacarbazine or Temozolomide in Patients Without Prior Therapy
Condition: Melanoma
Interventions: Drug: dacarbazine or temozolomide (choice);   Drug: CP-675,206
15 Recruiting Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: alemtuzumab;   Biological: alemtuzumab;   Biological: interferon beta-1a (Rebif®)
16 Active, not recruiting Study to Assess the Safety of CDP870 for up to 30 Months Following Reintroduction of Treatment
Condition: Crohn's Disease
Intervention: Biological: CDP870
17 Active, not recruiting Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: methotrexate;   Drug: pegylated liposomal doxorubicin hydrochloride;   Procedure: adjuvant therapy;   Procedure: radiation therapy
18 Recruiting A Study of Abatacept in Patients With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: abatacept;   Drug: placebo
19 Recruiting A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee
Condition: Osteoarthritis
Interventions: Drug: SD-6010;   Drug: SD-6010;   Drug: Placebo
20 Active, not recruiting A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: CCX282-B

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services